세계의 qPCR 시약 시장 규모 : 최종사용자별, 용도별, 포장 유형별, 탐지 방법별, 지역별, 범위 및 예측

qPCR Reagents Market Size And Forecast

qPCR Reagents Market size was valued at USD 2391.35 Million in 2023 and is projected to reach USD 4750.95 Million by 2031, growing at a CAGR of 8.96% during the forecast period 2024-2031. Global qPCR Reagents Market Drivers The market drivers for the qPCR Reagents Market can be influenced by various factors. These may include: Technological Developments:

By increasing the precision, sensitivity, and speed of qPCR tests, ongoing developments in qPCR technology, such as better reagents, devices, and software, fuel market expansion.

Growing Use in Research:

The market is growing as a result of the growing use of qPCR in a number of research fields, including transcriptomics, drug discovery, genomics, and molecular diagnostics. Viral load quantification, biomarker analysis, mutation detection, and gene expression analysis are all common uses for qPCR.

Growing Interest in Personalised Medicine:

As qPCR technology is used to identify genetic variations, disease markers, and treatment response prediction, it is becoming more and more important in the field of molecular diagnostics and personalised medicine. This has led to an increase in the demand for qPCR reagents.

Increase in Testing for Infectious Diseases:

The COVID-19 pandemic brought to light the significance of quick and precise diagnostic methods, such as qPCR, for infectious diseases. As a result, there is now a greater need for qPCR reagents for tracking and virus identification.

Growing Markets for Pharmaceuticals and Biotechnology:

The need for qPCR reagents for drug discovery, development, and validation procedures is driven by the growth of the biotechnology and pharmaceutical sectors as well as higher investment in research and development activities.

Automation and High-Throughput Systems:

As automated qPCR systems and high-throughput platforms become more common in labs and research centres, there is a greater need for qPCR reagents since these systems need specific reagents to function well.

Government Initiatives and financing:

By promoting the use of qPCR technology and reagents, supportive government initiatives, grants, and financing for research projects in molecular biology, genetics, and diagnostics contribute to market growth.

The need for qPCR reagents in clinical diagnostics is being driven by the increasing frequency of chronic diseases, which include cancer, cardiovascular disorders, and infectious diseases. These diseases require sensitive and accurate diagnostic techniques, like qPCR.

Global qPCR Reagents Market Restraints

Several factors can act as restraints or challenges for the qPCR Reagents Market. These may include:

High Cost:

The cost of qPCR reagents, including enzymes, primers, probes, and other components, can be relatively high, which may limit their adoption in certain research or diagnostic settings.

Complexity and Technical Expertise:

qPCR techniques require specialized equipment and technical expertise to perform accurately. This can be a barrier for small laboratories or researchers without the necessary resources.

Competition from Alternative Technologies:

Other molecular biology techniques like digital PCR (dPCR) and next-generation sequencing (NGS) offer alternative methods for nucleic acid quantification, posing competition to qPCR reagents.

Limited Sensitivity:

While qPCR is highly sensitive, it may not detect low-level gene expression changes or rare mutations as effectively as newer technologies like digital PCR.

Sample Integrity and Quality Control:

Maintaining sample integrity and ensuring quality control throughout the qPCR process can be challenging, leading to potential variability and reliability issues.

Regulatory Challenges:

Compliance with regulatory requirements, especially in diagnostic applications, can pose challenges for qPCR reagent manufacturers and users, impacting market growth.

Supply Chain Disruptions:

Disruptions in the supply chain, such as shortages of raw materials or manufacturing challenges, can affect the availability and pricing of qPCR reagents.

Limited Multiplexing Capacity:

Although multiplex qPCR assays are possible, they may have limitations in terms of the number of targets that can be simultaneously detected, affecting the scalability of qPCR applications.

Global qPCR Reagents Market: Segmentation Analysis

The Global qPCR Reagents Market is Segmented on the basis of End-User, Application, Packaging Type, Detection Method, and Geography.

qPCR Reagents Market, By End-User

• Pharmaceutical and Biotechnology Companies
• Forensic Laboratories
• Research Laboratories and Academic Institutes
• Hospitals and Diagnostic Centres
• Clinical Research Organization

Based on End-User, The market is segmented into Pharmaceutical and Biotechnology Companies, Forensic Laboratories, Research Laboratories and Academic Institutes, Hospitals and Diagnostic Centres, and Clinical Research organizations. The Hospitals and Diagnostic have the largest growth of the Global qPCR Reagents Market due to the dominant market position of hospitals and diagnostic centers can be credited to the advancement of the healthcare system for effective diagnosis and treatment, the rising proportion of qPCR reagents initiated for diagnostic applications, and the benefits provided by qPCR in the diagnosis of diseases.

qPCR Reagents Market, By Application

• Diagnostic Application
• Forensic Application
• Research Application

Based on Application, The market is segmented into Diagnostic Application, Forensic Application, and Research Application. The research application has the highest growth of the Global qPCR Reagents Market because of their increasing applications in fields including stem cell research, microbiology, and agricultural production as compared to other segments of the market during the forecasted period.

qPCR Reagents Market, By Packaging Type

• qPCR Core Kits
• qPCR Master Mixes

Based on Packaging Type, The market is segmented into qPCR Core Kits and qPCR Master Mixes. The qPCR Core Kits has the largest growth of the Global qPCR Reagents Market due to its large market share is driven by factors such as low core kit prices, end-user flexibility, rising private-public funding for life science research, and growing market provision of qPCR core kits in countries involved throughout the projected period.

qPCR Reagents Market, By Detection Method

• Dye-Based qPCR Reagents
• Probes and Primer-Based qPCR Reagents

Based on Detection Method, The market is segmented into Dye-Based qPCR Reagents and Probes and Primer-Based qPCR Reagents. The Dye-Based qPCR Reagent has the largest growth of the Global qPCR Reagents Market. Dye-based diagnostic qualitative PCR is being used rapidly to identify nucleic acids that are important in the diagnosis of infectious diseases, cancer, and genetic problems, among many other things. Furthermore, Cancer Research UK predicts that the number of cancer patients is expected to rise significantly.

qPCR Reagents Market, By Geography

• North America
• Europ
• Asia Pacific
• Rest of the world
• On the basis of Geography, The market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Asia-Pacific is projected to be the highest growing market over the forecasted period due to the high penetration of global life sciences companies in this region, increasing government focus on raising awareness about gene-based diagnostics and therapeutics, rising public and private incentives for the implementation of novel qPCR technology solutions, and progress of cancer research in Japan.

Key Players

• The major players in the qPCR Reagents Market are:
• Thermo Fischer Scientific Inc.
• Agilent Technologies
• Affymetrix Inc.
• Takara Bio. Inc
• Qiagen N.V
• Bio-Rad Laboratories
• Promega Corporation

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL QPCR REAGENTS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL QPCR REAGENTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL QPCR REAGENTS MARKET, BY END-USER

• 5.1 Overview
• 5.2 Pharmaceutical and Biotechnology Companies
• 5.3 Forensic Laboratories
• 5.4 Research Laboratories and Academic Institutes
• 5.5 Hospitals and Diagnostic Centres
• 5.6 Clinical Research Organization

6 GLOBAL QPCR REAGENTS MARKET, BY APPLICATIONS

• 6.1 Overview
• 6.2 Diagnostic Application
• 6.3 Forensic Application
• 6.4 Research Application

7 GLOBAL QPCR REAGENTS MARKET, BY PACKAGING TYPE

• 7.1 Overview
• 7.2 qPCR Core Kits
• 7.3 qPCR Master Mixes

8 GLOBAL QPCR REAGENTS MARKET, BY DETECTION METHOD

• 8.1 Overview
• 8.2 Dye-Based qPCR Reagents
• 8.3 Probes and Primer-Based qPCR Reagents

9 GLOBAL QPCR REAGENTS MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.3 Canada
  • 9.2.4 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Rest of the World
  • 9.5.1 Latin America
  • 9.5.2 Middle East and Africa

10 GLOBAL QPCR REAGENTS MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Development Strategies

11 COMPANY PROFILES

• 11.1 Qiagen N.V
  • 11.1.1 Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Outlook
  • 11.1.4 Key Developments
• 11.2 Bio-Rad Laboratories
  • 11.2.1 Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Outlook
  • 11.2.4 Key Developments
• 11.3 Agilent Technologies
  • 11.3.1 Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Outlook
  • 11.3.4 Key Developments
• 11.4 Takara Bio. Inc
  • 11.4.1 Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Outlook
  • 11.4.4 Key Developments
• 11.5 Thermo Fischer Scientific Inc.
  • 11.5.1 Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Outlook
  • 11.5.4 Key Developments
• 11.6 Affymetrix Inc.
  • 11.6.1 Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Outlook
  • 11.6.4 Key Developments
• 11.7 Promega Corporation
  • 11.7.1 Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Outlook
  • 11.7.4 Key Developments
• 11.8 Quanta Biosciences
  • 11.8.1 Overview
  • 11.8.2 Financial Performance
  • 11.8.3 Product Outlook
  • 11.8.4 Key Developments
• 11.9 F.Hoffman-La-Roche-Ltd
  • 11.9.1 Overview
  • 11.9.2 Financial Performance
  • 11.9.3 Product Outlook
  • 11.9.4 Key Developments

12 KEY DEVELOPMENTS

• 12.1 Product Launches/Developments
• 12.2 Mergers and Acquisitions
• 12.3 Business Expansions
• 12.4 Partnerships and Collaborations

13 Appendix

• 13.1 Related Research